Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Sustained Release Excipients Market, by Route of Administration
1.4.2 Europe Sustained Release Excipients Market, by Product
1.4.3 Europe Sustained Release Excipients Market, by Technology
1.4.4 Europe Sustained Release Excipients Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Sustained Release Excipients Market
Chapter 4. Europe Sustained Release Excipients Market by Route of Administration
4.1 Europe Oral Market by Country
4.2 Europe Transdermal Market by Country
4.3 Europe Vaginal Market by Country
4.4 Europe Intravenous Market by Country
4.5 Europe Ophthalmic Market by Country
4.6 Europe Subcutaneous Market by Country
4.7 Europe Intramuscular Market by Country
4.8 Europe Others Market by Country
Chapter 5. Europe Sustained Release Excipients Market by Product
5.1 Europe Polymers Market by Country
5.2 Europe Minerals Market by Country
5.3 Europe Sugars Market by Country
5.4 Europe Gelatin & Chitosan Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe Sustained Release Excipients Market by Technology
6.1 Europe Targeted Delivery Market by Country
6.2 Europe Implants Market by Country
6.3 Europe Wurster Technique Market by Country
6.4 Europe Transdermal Market by Country
6.5 Europe Micro Encapsulation Market by Country
6.6 Europe Coacervation & Others Market by Country
Chapter 7. Europe Sustained Release Excipients Market by Country
7.1 Germany Sustained Release Excipients Market
7.1.1 Germany Sustained Release Excipients Market by Route of Administration
7.1.2 Germany Sustained Release Excipients Market by Product
7.1.3 Germany Sustained Release Excipients Market by Technology
7.2 UK Sustained Release Excipients Market
7.2.1 UK Sustained Release Excipients Market by Route of Administration
7.2.2 UK Sustained Release Excipients Market by Product
7.2.3 UK Sustained Release Excipients Market by Technology
7.3 France Sustained Release Excipients Market
7.3.1 France Sustained Release Excipients Market by Route of Administration
7.3.2 France Sustained Release Excipients Market by Product
7.3.3 France Sustained Release Excipients Market by Technology
7.4 Russia Sustained Release Excipients Market
7.4.1 Russia Sustained Release Excipients Market by Route of Administration
7.4.2 Russia Sustained Release Excipients Market by Product
7.4.3 Russia Sustained Release Excipients Market by Technology
7.5 Spain Sustained Release Excipients Market
7.5.1 Spain Sustained Release Excipients Market by Route of Administration
7.5.2 Spain Sustained Release Excipients Market by Product
7.5.3 Spain Sustained Release Excipients Market by Technology
7.6 Italy Sustained Release Excipients Market
7.6.1 Italy Sustained Release Excipients Market by Route of Administration
7.6.2 Italy Sustained Release Excipients Market by Product
7.6.3 Italy Sustained Release Excipients Market by Technology
7.7 Rest of Europe Sustained Release Excipients Market
7.7.1 Rest of Europe Sustained Release Excipients Market by Route of Administration
7.7.2 Rest of Europe Sustained Release Excipients Market by Product
7.7.3 Rest of Europe Sustained Release Excipients Market by Technology
Chapter 8. Company Profiles
8.1 BASF SE
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 International Flavors & Fragrances, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segment & Regional Analysis
8.2.4 Research & Development Expense
8.3 Ashland Global Holdings Inc. (Pharmachem Laboratories Inc.)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.4 Evonik Industries AG (RAG-Stiftung)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisition and Mergers:
8.5 Croda International PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 Merck Group
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Pfizer, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional & Segmental Analysis
8.7.4 Research & Development Expense
8.8 Novartis AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 AstraZeneca PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.10. Gattefossé
8.10.1 Company Overview
Unique Offerings 
